Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?

Journal of Korean medical science - 10 May 2021

Jia Zaixing, Gong Wenping

Abstract excerpt

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which has spread worldwide since it was first identified in Wuhan, China, at the end of 2019. With the global transmission of the virus, a large number of SARS-CoV-2 variants have also appeared, especially, emerging strains that have recently been discovered in the United Kingdom (variant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Mutation

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33975397
DOI: 10.3346/jkms.2021.36.e124
PMCID: PMC8111046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?PMID 33975397Read ↗

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.Semantic proximity Read ↗

Research progress in spike mutations of SARS-CoV-2 variants and vaccine development.Semantic proximity Read ↗

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections.Semantic proximity Read ↗

Nucleocapsid as a next-generation COVID-19 vaccine candidateSemantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.Semantic proximity Read ↗

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.Semantic proximity Read ↗

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read ↗

Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine DevelopmentSemantic proximity Read ↗

Spike protein of SARS-CoV-2 variants: a brief review and practical implications.Semantic proximity Read ↗

The Genetic Variant of SARS-CoV-2: would It Matter for Controlling the Devastating Pandemic?Semantic proximity Read ↗

Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.